jueves, 1 de marzo de 2012

Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence|SAMHSA

Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid DependenceSAMHSA

Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence

Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence

Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence

Advisory - ELECTRONIC ONLY

Download Digital Version

Price: FREE (shipping charges may apply)
Gives an overview of extended-release injectable naltrexone (Vivitrol), a treatment for people with opioid dependence. Discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit from this treatment.


No hay comentarios:

Publicar un comentario